61 related articles for article (PubMed ID: 6805419)
1. Use of pyrazinamidase activity on Mycobacterium tuberculosis as a rapid method for determination of pyrazinamide susceptibility.
McClatchy JK; Tsang AY; Cernich MS
Antimicrob Agents Chemother; 1981 Oct; 20(4):556-7. PubMed ID: 6805419
[TBL] [Abstract][Full Text] [Related]
2. Role of metal ions on the activity of Mycobacterium tuberculosis pyrazinamidase.
Sheen P; Ferrer P; Gilman RH; Christiansen G; Moreno-Román P; Gutiérrez AH; Sotelo J; Evangelista W; Fuentes P; Rueda D; Flores M; Olivera P; Solis J; Pesaresi A; Lamba D; Zimic M
Am J Trop Med Hyg; 2012 Jul; 87(1):153-61. PubMed ID: 22764307
[TBL] [Abstract][Full Text] [Related]
3. Nicotinamidase/pyrazinamidase of Mycobacterium tuberculosis forms homo-dimers stabilized by disulfide bonds.
Rueda D; Sheen P; Gilman RH; Bueno C; Santos M; Pando-Robles V; Batista CV; Zimic M
Tuberculosis (Edinb); 2014 Dec; 94(6):644-8. PubMed ID: 25199451
[TBL] [Abstract][Full Text] [Related]
4. Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus.
Scorpio A; Zhang Y
Nat Med; 1996 Jun; 2(6):662-7. PubMed ID: 8640557
[TBL] [Abstract][Full Text] [Related]
5. Performance of Wayne assay for detection of pyrazinamide resistance in
Nasiri MJ; Fardsanei F; Arshadi M; Deihim B; Khalili F; Dadashi M; Goudarzi M; Mirsaeidi M
New Microbes New Infect; 2021 Jul; 42():100886. PubMed ID: 34141437
[TBL] [Abstract][Full Text] [Related]
6. The Bewildering Antitubercular Action of Pyrazinamide.
Lamont EA; Dillon NA; Baughn AD
Microbiol Mol Biol Rev; 2020 May; 84(2):. PubMed ID: 32132245
[TBL] [Abstract][Full Text] [Related]
7. A multiple genome analysis of Mycobacterium tuberculosis reveals specific novel genes and mutations associated with pyrazinamide resistance.
Sheen P; Requena D; Gushiken E; Gilman RH; Antiparra R; Lucero B; Lizárraga P; Cieza B; Roncal E; Grandjean L; Pain A; McNerney R; Clark TG; Moore D; Zimic M
BMC Genomics; 2017 Oct; 18(1):769. PubMed ID: 29020922
[TBL] [Abstract][Full Text] [Related]
8. Systematic review of mutations in pyrazinamidase associated with pyrazinamide resistance in Mycobacterium tuberculosis clinical isolates.
Ramirez-Busby SM; Valafar F
Antimicrob Agents Chemother; 2015 Sep; 59(9):5267-77. PubMed ID: 26077261
[TBL] [Abstract][Full Text] [Related]
9. 'Z(S)-MDR-TB' versus 'Z(R)-MDR-TB': improving treatment of MDR-TB by identifying pyrazinamide susceptibility.
Zhang Y; Chiu Chang K; Leung CC; Wai Yew W; Gicquel B; Fallows D; Kaplan G; Chaisson RE; Zhang W
Emerg Microbes Infect; 2012 Jul; 1(7):e5. PubMed ID: 26038418
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of Pyrazinamide Action and Resistance.
Zhang Y; Shi W; Zhang W; Mitchison D
Microbiol Spectr; 2013; 2(4):1-12. PubMed ID: 25530919
[TBL] [Abstract][Full Text] [Related]
11. Association between pncA gene mutations, pyrazinamidase activity, and pyrazinamide susceptibility testing in Mycobacterium tuberculosis.
Aono A; Chikamatsu K; Yamada H; Kato T; Mitarai S
Antimicrob Agents Chemother; 2014 Aug; 58(8):4928-30. PubMed ID: 24867972
[TBL] [Abstract][Full Text] [Related]
12. [Proposal of anti-tuberculosis regimens based on susceptibility to isoniazid and rifampicin].
Mendoza-Ticona A; Moore DA; Alarcón V; Samalvides F; Seas C
Rev Peru Med Exp Salud Publica; 2013 Apr; 30(2):197-204. PubMed ID: 23949502
[TBL] [Abstract][Full Text] [Related]
13. Pyrazinoic acid efflux rate in Mycobacterium tuberculosis is a better proxy of pyrazinamide resistance.
Zimic M; Fuentes P; Gilman RH; Gutiérrez AH; Kirwan D; Sheen P
Tuberculosis (Edinb); 2012 Jan; 92(1):84-91. PubMed ID: 22004792
[TBL] [Abstract][Full Text] [Related]
14. Pyrazinamide susceptibility testing in Mycobacterium tuberculosis: a systematic review with meta-analyses.
Chang KC; Yew WW; Zhang Y
Antimicrob Agents Chemother; 2011 Oct; 55(10):4499-505. PubMed ID: 21768515
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of colorimetric methods using nicotinamide for rapid detection of pyrazinamide resistance in Mycobacterium tuberculosis.
Mirabal NC; Yzquierdo SL; Lemus D; Madruga M; Milián Y; Echemendía M; Takiff H; Martin A; Van der Stuyf P; Palomino JC; Montoro E
J Clin Microbiol; 2010 Aug; 48(8):2729-33. PubMed ID: 20554826
[TBL] [Abstract][Full Text] [Related]
16. Sputum PCR-single-strand conformational polymorphism test for same-day detection of pyrazinamide resistance in tuberculosis patients.
Sheen P; Méndez M; Gilman RH; Peña L; Caviedes L; Zimic MJ; Zhang Y; Moore DA; Evans CA
J Clin Microbiol; 2009 Sep; 47(9):2937-43. PubMed ID: 19535526
[TBL] [Abstract][Full Text] [Related]
17. Effect of pyrazinamidase activity on pyrazinamide resistance in Mycobacterium tuberculosis.
Sheen P; Ferrer P; Gilman RH; López-Llano J; Fuentes P; Valencia E; Zimic MJ
Tuberculosis (Edinb); 2009 Mar; 89(2):109-13. PubMed ID: 19249243
[TBL] [Abstract][Full Text] [Related]
18. Comparative evaluation of Löwenstein-Jensen proportion method, BacT/ALERT 3D system, and enzymatic pyrazinamidase assay for pyrazinamide susceptibility testing of Mycobacterium tuberculosis.
Singh P; Wesley C; Jadaun GP; Malonia SK; Das R; Upadhyay P; Faujdar J; Sharma P; Gupta P; Mishra AK; Singh K; Chauhan DS; Sharma VD; Gupta UD; Venkatesan K; Katoch VM
J Clin Microbiol; 2007 Jan; 45(1):76-80. PubMed ID: 17093022
[TBL] [Abstract][Full Text] [Related]
19. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis in Brazil.
Rodrigues Vde F; Telles MA; Ribeiro MO; Cafrune PI; Rossetti ML; Zaha A
Antimicrob Agents Chemother; 2005 Jan; 49(1):444-6. PubMed ID: 15616332
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
